Serum gamma-glutamyltransferase is strongly linked to obesity and non-alcoholic fatty liver disease, which may lead to systemic and hepatic insulin resistance, respectively66. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.